The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
2011

The IL23R R381Q Gene Variant and Its Role in Immune-Mediated Diseases

Sample size: 176 publication 10 minutes Evidence: moderate

Author Information

Author(s): Di Meglio Paola, Di Cesare Antonella, Laggner Ute, Chu Chung-Ching, Napolitano Luca, Villanova Federica, Tosi Isabella, Capon Francesca, Trembath Richard C., Peris Ketty, Nestle Frank O.

Primary Institution: St. John's Institute of Dermatology, King's College London

Hypothesis

Does the IL23R R381Q SNP affect IL-23/IL-23R signaling and impair Th17 responses?

Conclusion

The IL23R R381Q gene variant impairs IL-23-induced Th17 effector function without affecting Th17 differentiation.

Supporting Evidence

  • The IL23R R381Q gene variant had no major effect on Th17 cell differentiation.
  • Th17 cells from A allele carriers produced significantly less IL-17A in response to IL-23.
  • IL-23-induced STAT3 phosphorylation was significantly reduced in Th17 cells from A allele carriers.

Takeaway

A specific gene variant can help protect people from certain diseases by making their immune response less aggressive.

Methodology

The study involved genotyping healthy donors for the IL23R R381Q variant and analyzing Th17 cell responses to IL-23 stimulation.

Potential Biases

Potential bias due to the exclusion of patients who may have confounding genetic variants.

Limitations

The study was limited to healthy donors without a personal or family history of immune-mediated disorders.

Participant Demographics

Healthy individuals of Western European descent, with 14 males and 27 females in the functional study.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017160

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication